Trials / Completed
CompletedNCT05683951
Clinical Trial to Evaluate the Efficacy and Safety of DWKH
Phase III Clinical Trial to Evaluate the Efficacy and Safety of DWKH
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 186 (actual)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Randomized, Double-blind, Parellel, Multicenter, Active-controlled
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWKH | Administration of DWKH three times daily |
| DRUG | DWKH-R | Administration of DWKH-R three times daily |
| DRUG | Placebo | Administration of Placebo three times daily |
Timeline
- Start date
- 2021-11-26
- Primary completion
- 2022-12-09
- Completion
- 2022-12-16
- First posted
- 2023-01-13
- Last updated
- 2023-01-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05683951. Inclusion in this directory is not an endorsement.